Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
QuintilesIMS
Farmers Insurance
Fish and Richardson
Chubb
US Army
Covington
Deloitte

Generated: April 23, 2018

DrugPatentWatch Database Preview

BLOXIVERZ Drug Profile

« Back to Dashboard

When do Bloxiverz patents expire, and what generic alternatives are available?

Bloxiverz is a drug marketed by Avadel Legacy and is included in one NDA.

The generic ingredient in BLOXIVERZ is neostigmine methylsulfate. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
Drug patent expirations by year for BLOXIVERZ
Pharmacology for BLOXIVERZ
Medical Subject Heading (MeSH) Categories for BLOXIVERZ
Synonyms for BLOXIVERZ
(3-(Dimethylcarbamoxy)phenyl)trimethylammonium methyl sulfate
(3-(Dimethylcarbamoyl)oxyphenyl)trimethylammonium methyl sulfate
(3-Dimethylcarbamoyloxyphenyl)trimethylammonium Methyl Sulfate
(3-Hydroxyphenyl)trimethylammonium Methyl Sulfate Dimethylcarbamate
(3-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamic ester
(m-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamate
[3-(Dimethylcarbamoxy)phenyl]trimethylammonium methyl sulfate
[3-(Dimethylcarbamoyl)oxyphenyl]trimethylammonium methyl sulfate
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium; methyl sulfate
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; methyl sulfate
[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium; methyl sulfate
[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;methyl sulfate
[3-[dimethylamino(oxo)methoxy]phenyl]-trimethylammonium; methyl sulfate
3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium methyl sulfate
3-(Dimethylcarbamoxy)phenyl trimethylammonium methyl sulfate
3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium methyl sulfate
3-[([Dimethylamino]carbonyl)-oxy]-N,N,N-trimethylbenzaminium methyl sulfate
3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium methyl sulfate
3-[[ carbonyl]oxy]-N,N,N-trimethylbenzenaminiummethylsulfate
3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium methyl sulfate
51-60-5
59-99-4 (Parent)
98IMH7M386
A828681
AB0016660
AC-6847
AC1L1L7Z
AC1Q61EU
ACMC-1BNDZ
ACT05636
AK162163
AKOS015856682
Ammonium, (3-(dimethylcarbamoyloxy)phenyl)trimethyl-, methylsulfate
Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate
Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate (8CI)
Ammonium, methyl sulfate, dimethylcarbamate
AN-881
ANW-43286
API0003539
AR-32
AS-15291
AX8083294
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, methyl sulfate
Benzenaminium,N,N-trimethyl-, methyl sulfate
Bloxiverz (TN)
C08200
C12H19N2O2
C13H22N2O6S
Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium methyl sulfate
Carbamic acid, ester with (m-hydroxyphenyl)trimethylammonium methyl sulfate
Carbamic acid, N,N-dimethyl-, 3-(trimethylammonio)phenyl ester, methylsulfate
Carbamic acid, N,N-dimethyl-, 3-dimethylaminophenyl ester, methosulfate
Carbamic acid,N-dimethyl-, 3-(trimethylammonio)phenyl ester, methyl sulfate
CCG-213722
CCRIS 3274
CHEBI:7516
CHEMBL211471
CS-4698
CTK3J3206
D00998
Dimethylcarbamic ester of 3-oxyphenyltrimethylammonium methylsulfate
Dimethylcarbamic ester of 3-oxyphenyltrimethylammonium methylsulfato
DR001607
DTXSID40199003
EINECS 200-109-5
Eustigmin methyl sulfate
Eustigmin methylsulfate
FT-0603223
GD 65
HMS2234E04
HMS3371E13
HMS500J20
Hodostin
HY-B1206
I14-5828
Kirkstigmine
Kirkstigmine methyl sulfate
KS-00000XR6
KSC493E0N
Leostigmine methyl sulfate
LS-28448
MCULE-5178407195
MFCD00011796
MLS000028383
MLS001148660
MLS001333720
MolPort-003-849-354
N,N-dimethyl[3-(trimethylamino)phenoxy]carboxamide, methyl hydroxysulfonate
N0447
Neoeserine methyl sulfate
Neostigmeth
Neostigmine (methyl sulfate)
Neostigmine methosulfate
Neostigmine methyl sulfate
Neostigmine methyl sulfate, European Pharmacopoeia (EP) Reference Standard
Neostigmine methyl sulfate, United States Pharmacopeia (USP) Reference Standard
NEOSTIGMINE METHYL SULFATE(1-)
NEOSTIGMINE METHYLSULFATE
Neostigmine methylsulfate (JP17/USP)
Neostigmine Methylsulfate [USAN:JAN]
Neostigmine methylsulfate [USP:JAN]
Neostigmine methylsulphate
Neostigmine metilsulfate
Neostigmine monomethyl sulfate
Neostigmine monomethylsulfate
Neostigminmetilsulfat
Normastigmin
NSC 93753
NSC-93753
NSC93753
O811
Opera_ID_536
OR164930
Philostigmin methyl sulfate
Polstigmine
Proserin
Proserine
Proserine methyl sulfate
Proserinum
Prostigmin
Prostigmin methyl sulfate
Prostigmine methyl sulfate
RTR-018376
SB-23
SCHEMBL41903
SMR000058592
ST51006794
Stigmanol methyl sulfate
Stigmosan methyl sulfate
Synstigmine
Synthostigmine methyl sulfate
Syntostigmin
Syntostigmin (injection)
Syntostigmin (VAN)
Syntostigmin methyl sulfate
Syntostigmine methyl sulfate
TL-1394
TR-018376
UNII-98IMH7M386
Vagostigmine methyl sulfate
WLN: 1N1&VOR CK1&1&1 &Q &OSW1

US Patents and Regulatory Information for BLOXIVERZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avadel Legacy BLOXIVERZ neostigmine methylsulfate SOLUTION;INTRAVENOUS 204078-001 May 31, 2013 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Avadel Legacy BLOXIVERZ neostigmine methylsulfate SOLUTION;INTRAVENOUS 204078-002 May 31, 2013 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Harvard Business School
McKesson
Healthtrust
QuintilesIMS
Farmers Insurance
Chubb
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.